Results 131 to 140 of about 86,778 (305)

Integrated use of natriuretic peptides and DASI for cardiac reserve evaluation in high-risk surgical patients: a narrative review

open access: yesJournal of Anesthesia, Analgesia and Critical Care
Background The perioperative management of high-risk patients undergoing major noncardiac surgery remains a significant challenge in modern healthcare.
Tarek Senussi Testa   +6 more
doaj   +1 more source

Persistent Pulmonary Hypertension of the Newborn: A Pragmatic Review of Pathophysiology, Diagnosis, and Advances in Management

open access: yesBiomedicines
Persistent pulmonary hypertension of the newborn (PPHN) results from disrupted fetal–neonatal circulatory transition, characterized by elevated pulmonary vascular resistance (PVR), right-to-left shunting, and refractory hypoxemia.
Karolina Chojnacka   +5 more
doaj   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Low prevalence of B-type natriuretic peptide levels

open access: yes, 2006
Background: In patients with acute heart failure (HF) presenting at the emergency department, a B-type natriuretic peptide (BNP ...
Hoes, A.W.   +5 more
core   +3 more sources

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh   +18 more
wiley   +1 more source

Clinical value of BNP and NT-proBNP for evaluating the cardiac function of patients with chronic renal failure

open access: yesLinchuang shenzangbing zazhi, 2016
Objective To investigate the clinical value of B-type natriuretic peptide(BNP) and N-terminal pro-B type natriuretic peptide(NT-proBNP) for evaluating the cardiac function of patients with chronic renal failure(CRF).Methods 120 inpatients with CRF were ...
TANG Li, LIAO Chang-bin, ZHONG Chun-mei
doaj  

Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1326-1335, April 2025.
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer   +25 more
wiley   +1 more source

B-type natriuretic peptide (BNP), not ANP, is the principal cardiac natriuretic peptide in vertebrates as revealed by comparative studies

open access: yes, 2011
B-type natriuretic peptide (BNP), not ANP, is the principal cardiac natriuretic peptide in vertebrates as revealed by comparative ...
K Inoue (13291473)   +3 more
core  

Single-cell analysis identifies the CNP/GC-B/cGMP axis as marker and regulator of modulated VSMCs in atherosclerosis

open access: yesNature Communications
A balanced activity of cGMP signaling contributes to the maintenance of cardiovascular homeostasis. Vascular smooth muscle cells (VSMCs) can generate cGMP via three ligand-activated guanylyl cyclases, the NO-sensitive guanylyl cyclase, the atrial ...
Moritz Lehners   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy